{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2019-nCoV", "COVID-19", "antiviral potential", "coronavirus", "epidemiology", "mode of action", "phylogenetic", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33679384", "DateRevised": {"Year": "2023", "Month": "09", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "17"}], "Language": ["eng"], "ELocationID": ["586993", "10.3389/fphar.2020.586993"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.", "Pagination": {"StartPage": "586993", "MedlinePgn": "586993"}, "Abstract": {"AbstractText": ["The emergence of viral pneumonia caused by a novel coronavirus (CoV), known as the 2019 novel coronavirus (2019-nCoV), resulted in a contagious acute respiratory infectious disease in December 2019 in Wuhan, Hubei Province, China. Its alarmingly quick transmission to many countries across the world and a considerable percentage of morbidity and mortality made the World Health Organization recognize it as a pandemic on March 11, 2020. The perceived risk of infection has led many research groups to study COVID-19 from different aspects. In this literature review, the phylogenetics and taxonomy of COVID-19 coronavirus, epidemiology, and respiratory viruses similar to COVID-19 and their mode of action are documented in an approach to understand the behavior of the current virus. Moreover, we suggest targeting the receptors of SARS-CoV and SARS-CoV-2 such as ACE2 and other proteins including 3CLpro and PLpro for improving antiviral activity and immune response against COVID-19 disease. Additionally, since phytochemicals play an essential role in complementary therapies for viral infections, we summarized different bioactive natural products against the mentioned respiratory viruses with a focus on influenza A, SARS-CoV, MERS, and COVID-19.Based on current literature, 130 compounds have antiviral potential, and of these, 94 metabolites demonstrated bioactivity against coronaviruses. Interestingly, these are classified in different groups of natural products, including alkaloids, flavonoids, terpenoids, and others. Most of these compounds comprise flavonoid skeletons. Based on our survey, xanthoangelol E (<b>88</b>), isolated from <i>Angelica keiskei</i> (Miq.) Koidz showed inhibitory activity against SARS-CoV PLpro with the best IC<sub>50</sub> value of 1.2\u00a0\u03bcM. Additionally, hispidulin (<b>3</b>), quercetin (<b>6</b>), rutin (<b>8</b>), saikosaponin D (<b>36</b>), glycyrrhizin (<b>47</b>), and hesperetin (<b>55</b>) had remarkable antiviral potential against different viral infections. Among these compounds, quercetin (<b>6</b>) exhibited antiviral activities against influenza A, SARS-CoV, and COVID-19 and this seems to be a highly promising compound. In addition, our report discusses the obstacles and future perspectives to highlight the importance of developing screening programs to investigate potential natural medicines against COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 Omrani, Keshavarz, Nejad Ebrahimi, Mehrabi, McGaw, Ali Abdalla and Mehrbod."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Omrani", "ForeName": "Marzieh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Virology, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran."}], "LastName": "Keshavarz", "ForeName": "Mohsen", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Nejad Ebrahimi", "ForeName": "Samad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shafa Hospital, Qazvin University of Medical Sciences, Qazvin, Iran."}], "LastName": "Mehrabi", "ForeName": "Meysam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa."}], "LastName": "McGaw", "ForeName": "Lyndy J", "Initials": "LJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Technology, Faculty of Agriculture, University of Khartoum, Khartoum North, Sudan."}], "LastName": "Ali Abdalla", "ForeName": "Muna", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran."}], "LastName": "Mehrbod", "ForeName": "Parvaneh", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aanouz I., Belhassan A., El-Khatabi K., Lakhlifi T., El-ldrissi M., Bouachrine M. (2020). Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations. J. Biomol. Struct. Dyn. 10, 1\u20139. 10.1080/07391102.2020.1758790", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Adem S., Eyupoglu V., Sarfraz I., Rasul A., Ali M. (2020). Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA.", "ArticleIdList": ["PMC8957318", "35364308"]}, {"Citation": "Akinwumi B. C., Bordun K.-A. M., Anderson H. D. (2018). Biological activities of stilbenoids. Int. J. Mol. Sci. 19 (3), 792. 10.3390/ijms19030792", "ArticleIdList": ["10.3390/ijms19030792", "PMC5877653", "29522491"]}, {"Citation": "Bang S., Li W., Ha T. K. Q., Lee C., Oh W. K., Shim S. H. (2018). Anti-influenza effect of the major flavonoids from Salvia plebeia R.Br. via inhibition of influenza H1N1 virus neuraminidase. Nat. Prod. Res. 32 (10), 1224\u20131228. 10.1080/14786419.2017.1326042", "ArticleIdList": ["10.1080/14786419.2017.1326042", "28504013"]}, {"Citation": "Bang S., Quy Ha T. K., Lee C., Li W., Oh W. K., Shim S. H. (2016). Antiviral activities of compounds from aerial parts of Salvia plebeia R. Br. J. Ethnopharmacol. 192, 398\u2013405. 10.1016/j.jep.2016.09.030", "ArticleIdList": ["10.1016/j.jep.2016.09.030", "27647011"]}, {"Citation": "Belouzard S., Millet J. K., Licitra B. N., Whittaker G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4 (6), 1011\u20131033. 10.3390/v4061011", "ArticleIdList": ["10.3390/v4061011", "PMC3397359", "22816037"]}, {"Citation": "Cao D., Liu Z., Verwilst P., Koo S., Jangjili P., Kim J. S., Lin W. (2019). Coumarin-based small-molecule fluorescent chemosensors. Chem. Rev. 119 (18), 10403\u201310519. 10.1021/acs.chemrev.9b00145", "ArticleIdList": ["10.1021/acs.chemrev.9b00145", "31314507"]}, {"Citation": "Chang S. Y., Park J. H., Kim Y. H., Kang J. S., Min J. Y. (2016). A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein. Biochem. Biophys. Res. Commun. 471 (2), 282\u2013289. 10.1016/j.bbrc.2016.01.123", "ArticleIdList": ["10.1016/j.bbrc.2016.01.123", "26850850"]}, {"Citation": "Chen C. N., Lin C. P., Huang K. K., Chen W. C., Hsieh H. P., Liang P. H., et al. (2005). Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3). Evid. Based Complem. Alternat. Med. 2, 209. 10.1093/ecam/neh081", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Chen F., Chan K., Jiang Y., Kao R., Lu H., Fan K. (2004). In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 31 (1), 69\u201375. 10.1016/j.jcv.2004.03.003", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Chen H., Du Q. (2020). Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints."}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G. (2006). Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg. Med. Chem. 14 (24), 8295\u20138306. 10.1016/j.bmc.2006.09.014", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Cheng A. X., Lou Y. G., Mao Y. B., Lu S., Wang L. J., Chen X. Y. (2007). Plant terpenoids: biosynthesis and ecological functions. J. Integr. Plant Biol. 49 (2), 179\u2013186. 10.1111/j.1744-7909.2007.00395.x", "ArticleIdList": ["10.1111/j.1744-7909.2007.00395.x"]}, {"Citation": "Cheng J., Tang Y., Bao B., Zhang P. (2020a). Exploring the active compounds of traditional Mongolian medicine agsirga in intervention of novel coronavirus (2019-nCoV) based on HPLC-Q-exactive-MS/MS and molecular docking method.", "ArticleIdList": ["PMC7225714", "32421102"]}, {"Citation": "Cheng L., Zheng W., Li M., Huang J., Bao S., Xu Q., Ma Z. (2020b). Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.", "ArticleIdList": ["PMC8844329", "35157175"]}, {"Citation": "Cheng P. W., Ng L. T., Chiang L. C., Lin C. C. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in vitro . Clin. Exp. Pharmacol. Physiol. 33 (7), 612\u2013616. 10.1111/j.1440-1681.2006.04415.x", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Cho J. K., Curtis-Long M. J., Lee K. H., Kim D. W., Ryu H. W., Yuk H. J., et al. (2013). Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa . Bioorg. Med. Chem. 21 (11), 3051\u20133057. 10.1016/j.bmc.2013.03.027", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (9374), 2045\u20132046. 10.1016/s0140-6736(03)13615-x", "ArticleIdList": ["10.1016/s0140-6736(03)13615-x", "PMC7112442", "12814717"]}, {"Citation": "Contreras-Puentes N., Alv\u00edz-Amador A. (2020). Virtual screening of natural metabolites and antiviral drugs with potential inhibitory activity against 3CL-PRO and PL-PRO. Biomed. Pharmacol. J. 13 (2), 933\u2013941. 10.13005/bpj/1962.33851", "ArticleIdList": ["10.13005/bpj/1962.33851"]}, {"Citation": "da Silva Antonio A., Wiedemann L. S. M., Veiga-Junior V. F. (2020). Natural products' role against COVID-19. RSC Adv. 10 (39), 23379\u201323393. 10.1039/D0RA03774E", "ArticleIdList": ["10.1039/D0RA03774E", "PMC9122563", "35693131"]}, {"Citation": "Dao T. T., Dang T. T., Nguyen P. H., Kim E., Thuong P. T., Oh W. K. (2012). Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. Bioorg. Med. Chem. Lett. 22 (11), 3688\u20133692. 10.1016/j.bmcl.2012.04.028", "ArticleIdList": ["10.1016/j.bmcl.2012.04.028", "22552195"]}, {"Citation": "Dao T. T., Nguyen P. H., Lee H. S., Kim E., Park J., Lim S. I., et al. (2011). Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata . Bioorg. Med. Chem. Lett. 21 (1), 294\u2013298. 10.1016/j.bmcl.2010.11.016", "ArticleIdList": ["10.1016/j.bmcl.2010.11.016", "21123068"]}, {"Citation": "Dao T. T., Tung B. T., Nguyen P. H., Thuong P. T., Yoo S. S., Kim E. H., et al. (2010). C-methylated flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase. J. Nat. Prod. 73 (10), 1636\u20131642. 10.1021/np1002753", "ArticleIdList": ["10.1021/np1002753", "20886838"]}, {"Citation": "Das S., Sarmah S., Lyndem S., Singha Roy A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J. Biomol. Struct. Dyn. 10, 1\u201318.", "ArticleIdList": ["PMC7232884", "32362245"]}, {"Citation": "Day A. J., Bao Y., Morgan M. R., Williamson G. (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med. 29 (12), 1234\u20131243. 10.1016/s0891-5849(00)00416-0", "ArticleIdList": ["10.1016/s0891-5849(00)00416-0", "11118813"]}, {"Citation": "Di Sotto A., Checconi P., Celestino I., Locatelli M., Carissimi S., De Angelis M., et al. (2018). Antiviral and antioxidant activity of a hydroalcoholic extract from Humulus lupulus L. Oxid. Med. Cell Longev. 2018, 5919237. 10.1155/2018/5919237", "ArticleIdList": ["10.1155/2018/5919237", "PMC6081516", "30140367"]}, {"Citation": "Elfiky A. A. (2020). Natural products may interfere with SARS-CoV-2 attachment to the host cell. J. Biomol. Struct. Dyn. 8, 1\u201310. 10.1080/07391102.2020.1761881", "ArticleIdList": ["10.1080/07391102.2020.1761881", "PMC7212544", "32340551"]}, {"Citation": "Filardo S., Di Pietro M., Mastromarino P., Sessa R. (2020). Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol. Therapeut. 2020, 107613. 10.1016/j.pharmthera", "ArticleIdList": ["10.1016/j.pharmthera", "32562826"]}, {"Citation": "Gautret P., Lagier J. C., Parola P., Hoang V. T., Meddeb L., Mailhe M. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 56 (1), 105949. 10.1016/j.ijantimicag.2020.105949", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105949", "PMC7102549", "32205204"]}, {"Citation": "Goswami D., Kumar M., Ghosh S. K., Das A. (2020). Natural product compounds in Alpinia officinarum and ginger are potent SARS-CoV-2 papain-like protease inhibitors."}, {"Citation": "Grienke U., Mair C. E., Kirchmair J., Schmidtke M., Rollinger J. M. (2018). Discovery of bioactive natural products for the treatment of acute respiratory infections\u2014an integrated approach. Planta Med. 84 (09/10), 684\u2013695. 10.1055/a-0590-5153", "ArticleIdList": ["10.1055/a-0590-5153", "29554706"]}, {"Citation": "Grienke U., Richter M., Walther E., Hoffmann A., Kirchmair J., Makarov V. (2016). Discovery of phenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Sci. Rep. 6 (1), 27156\u201327211. 10.1038/srep27156", "ArticleIdList": ["10.1038/srep27156", "PMC4891693", "27257160"]}, {"Citation": "Grienke U., Schmidtke M., Kirchmair J., Pfarr K., Wutzler P., D\u00fcrrwald R. (2010). Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J. Med. Chem. 53 (2), 778\u2013786. 10.1021/jm901440f", "ArticleIdList": ["10.1021/jm901440f", "20014777"]}, {"Citation": "Harborne J. B., Marby H., Marby T. (2013). The flavonoids. New York, NY: Springer."}, {"Citation": "Hasan A., Paray B. A., Hussain A., Qadir F. A., Attar F., Aziz F. M., et al. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J. Biomol. Struct. Dyn., 22, 1\u20139. 10.1080/07391102.2020.1754293", "ArticleIdList": ["10.1080/07391102.2020.1754293", "PMC7189411", "32274964"]}, {"Citation": "Ho T. Y., Wu S. L., Chen J. C., Li C. C., Hsiang C. Y. (2007). Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 74 (2), 92\u2013101. 10.1016/j.antiviral.2006.04.014", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181 (2), 271\u2013280. 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Hossan M. S., Fatima A., Rahmatullah M., Khoo T. J., Nissapatorn V., Galochkina A. V., et al. (2018). Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro . Arch. Virol. 163 (8), 2121\u20132131. 10.1007/s00705-018-3842-6", "ArticleIdList": ["10.1007/s00705-018-3842-6", "29633078"]}, {"Citation": "Hu K., Guan W. J., Bi Y., Zhang W., Li L., Zhang B., et al. (2020). Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial in patients with Coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine, 2020, 153242. 10.1016/j.phymed.2020.153242", "ArticleIdList": ["10.1016/j.phymed.2020.153242", "PMC7229744", "33867046"]}, {"Citation": "Huang X., Dong W., Milewska A., Golda A., Qi Y., Zhu Q. K., et al. (2015). Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme. J. Virol. 89 (14), 7202\u20137213. 10.1128/JVI.00854-15", "ArticleIdList": ["10.1128/JVI.00854-15", "PMC4473545", "25926653"]}, {"Citation": "Hwang B. S., Lee M. S., Lee S. W., Lee I. K., Seo G. S., Choi H. J., Yun B. S. (2014). Neuraminidase inhibitors from the fermentation broth of Phellinus linteus. Mycobiology 42 (2), 189\u2013192. 10.5941/MYCO.2014.42.2.189", "ArticleIdList": ["10.5941/MYCO.2014.42.2.189", "PMC4112237", "25071390"]}, {"Citation": "Ibrahim A. K., Youssef A. I., Arafa A. S., Ahmed S. A. (2013). Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Nat. Prod. Res. 27 (22), 2149\u20132153. 10.1080/14786419.2013.790027", "ArticleIdList": ["10.1080/14786419.2013.790027", "23651316"]}, {"Citation": "Ibrahim I. M., Abdelmalek D. H., Elshahat M. E., Elfiky A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. J. Infect.", "ArticleIdList": ["PMC7102553", "32169481"]}, {"Citation": "Islam N., Sharp S. J., Chowell G., Shabnam S., Kawachi I., Lacey B., et al. (2020). Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries.", "ArticleIdList": ["PMC7360923", "32669358"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 35 (1), 145\u2013151. 10.1080/14756366.2019.1690480", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Joshi R. S., Jagdale S. S., Bansode S. B., Shankar S. S., Tellis M. B., Pandya V. K., et al. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J. Biomol. Struct. Dyn., 28, 1\u201316. 10.1080/07391102.2020.1760137", "ArticleIdList": ["10.1080/07391102.2020.1760137", "PMC7212545", "32329408"]}, {"Citation": "Gamaleldin Elsadig Karar M., Matei M. F., Jaiswal R., Illenberger S., Kuhnert N. (2016). Neuraminidase inhibition of Dietary chlorogenic acids and derivatives\u2014potential antivirals from dietary sources. Food Funct. 7 (4), 2052\u20132059. 10.1039/c5fo01412c", "ArticleIdList": ["10.1039/c5fo01412c", "27010419"]}, {"Citation": "Khandelwal A., Sharma T. (2020). Computational screening of phytochemicals from medicinal plants as COVID-19 inhibitors."}, {"Citation": "Kim D. W., Seo K. H., Curtis-Long M. J., Oh K. Y., Oh J. W., Cho J. K., et al. (2014). Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzym. Inhib. Med. Chem. 29 (1), 59\u201363. 10.3109/14756366.2012.753591", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Kim H. Y., Shin H. S., Park H., Kim Y. C., Yun Y. G., Park S., et al. (2008). In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptis rhizoma, and Phellodendron cortex. J. Clin. Virol. 41 (2), 122\u2013128. 10.1016/j.jcv.2007.10.011", "ArticleIdList": ["10.1016/j.jcv.2007.10.011", "PMC7108295", "18036887"]}, {"Citation": "Kim J. Y., Kim Y. I., Park S. J., Kim I. K., Choi Y. K., Kim S. H. (2018). Safe, high-throughput screening of natural compounds of mers-cov entry inhibitors using a pseudovirus expressing mers-cov spike protein. Int. J. Antimicrob. Agents 52 (5), 730. 10.1016/j.ijantimicag.2018.05.003", "ArticleIdList": ["10.1016/j.ijantimicag.2018.05.003", "PMC7125825", "29772395"]}, {"Citation": "Kim M., Kim S. Y., Lee H. W., Shin J. S., Kim P., Jung Y. S., et al. (2013). Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate. Antivir. Res. 100 (2), 460\u2013472. 10.1016/j.antiviral.2013.08.002", "ArticleIdList": ["10.1016/j.antiviral.2013.08.002", "23954192"]}, {"Citation": "Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., et al. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 (8), 875\u2013879. 10.1038/nm1267", "ArticleIdList": ["10.1038/nm1267", "PMC7095783", "16007097"]}, {"Citation": "Kumar A., Choudhir G., Shukla S. K., Sharma M., Tyagi P., Bhushan A., et al. (2020). Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J. Biomol. Struct. Dyn., 12, 1\u201321. (just-accepted)", "ArticleIdList": ["PMC7284142", "32448034"]}, {"Citation": "Law A. H., Yang C. L., Lau A. S., Chan G. C. (2017). Antiviral effect of forsythoside A from Forsythia suspensa (Thunb.) Vahl fruit against influenza A virus through reduction of viral M1 protein. J. Ethnopharmacol. 209, 236\u2013247. 10.1016/j.jep.2017.07.015", "ArticleIdList": ["10.1016/j.jep.2017.07.015", "28716571"]}, {"Citation": "Lee C. L., Chiang L. C., Cheng L. H., Liaw C. C., Abd El-Razek M. H., Chang F. R., et al. (2009). Influenza A (H(1)N(1)) antiviral and cytotoxic agents from Ferula assa-foetida. J Nat Prod 72 (9), 1568\u20131572. 10.1021/np900158f", "ArticleIdList": ["10.1021/np900158f", "19691312"]}, {"Citation": "Li W., Greenough T. C., Moore M. J., Vasilieva N., Somasundaran M., Sullivan J. L., et al. (2004). Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. J. Virol. 78 (20), 11429\u201311433. 10.1128/JVI.78.20.11429-11433.2004", "ArticleIdList": ["10.1128/JVI.78.20.11429-11433.2004", "PMC521845", "15452268"]}, {"Citation": "Li F., Li W., Farzan M., Harrison S. C. (2005a). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 (5742), 1864\u20131868. 10.1126/science.1116480", "ArticleIdList": ["10.1126/science.1116480", "16166518"]}, {"Citation": "Li S. Y., Chen C., Zhang H. Q., Guo H. Y., Wang H., Wang L., et al. (2005b). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 67 (1), 18\u201323. 10.1016/j.antiviral.2005.02.007", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Li W., Zhang C., Sui J., Kuhn J. H., Moore M. J., Luo S., et al. (2005c). Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24 (8), 1634\u20131643. 10.1038/sj.emboj.7600640", "ArticleIdList": ["10.1038/sj.emboj.7600640", "PMC1142572", "15791205"]}, {"Citation": "Li B., Ni Y., Zhu L. J., Wu F. B., Yan F., Zhang X., et al. (2015). Flavonoids from matteuccia struthiopteris and their anti-influenza virus (H1N1) activity. J. Nat. Prod. 78 (5), 987\u2013995. 10.1021/np500879t", "ArticleIdList": ["10.1021/np500879t", "25927664"]}, {"Citation": "Li X., Yang Y., Liu L., Yang X., Zhao X., Li Y., et al. (2020). Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019. Pharmacol. Res. 160, 105036. 10.1016/j.phrs.2020.105036", "ArticleIdList": ["10.1016/j.phrs.2020.105036", "PMC7301803", "32565309"]}, {"Citation": "Lin C. W., Tsai F. J., Tsai C. H., Lai C. C., Wan L., Ho T. Y., et al. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir. Res. 68 (1), 36\u201342. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Luo E., Zhang D., Luo H., Liu B., Zhao K., Zhao Y., et al. (2020). Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China. Chin. Med. 15, 1\u201313.", "ArticleIdList": ["PMC7156896", "32308732"]}, {"Citation": "Marinella M. A. (2020). Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19. Int. J. Clin. Pract., 74, e13535. 10.1111/ijcp.13535", "ArticleIdList": ["10.1111/ijcp.13535", "PMC7261995", "32412158"]}, {"Citation": "McCray P. B., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., et al. (2007). Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81 (2), 813\u2013821. 10.1128/JVI.02012-06", "ArticleIdList": ["10.1128/JVI.02012-06", "PMC1797474", "17079315"]}, {"Citation": "Mehrbod P., Abdalla M. A., Fotouhi F., Heidarzadeh M., Aro A. O., Eloff J. N., et al. (2018). Immunomodulatory properties of quercetin-3-O-\u03b1-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Compl. Alternative Med. 18 (1), 184\u2013210. 10.1186/s12906-018-2246-1", "ArticleIdList": ["10.1186/s12906-018-2246-1", "PMC6003079", "29903008"]}, {"Citation": "Mehrbod P., Ebrahimi S. N., Fotouhi F., Eskandari F., Eloff J. N., McGaw L. J., et al. (2019). Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-\u03b1-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos. BMC Compl. Alternative Med. 19 (1), 1\u201311. 10.1186/s12906-019-2774-3", "ArticleIdList": ["10.1186/s12906-019-2774-3", "PMC6888925", "31791311"]}, {"Citation": "Miki K., Nagai T., Suzuki K., Tsujimura R., Koyama K., Kinoshita K., et al. (2007). Anti-influenza virus activity of biflavonoids. Bioorg. Med. Chem. Lett 17 (3), 772\u2013775. 10.1016/j.bmcl.2006.10.075", "ArticleIdList": ["10.1016/j.bmcl.2006.10.075", "17110111"]}, {"Citation": "Mittra I., de Souza R., Bhadade R., Madke T., Shankpal P., Joshi M., et al. (2020). Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002). medRxiv."}, {"Citation": "Monajjemi M., Mollaamin F., Shojaei S. (2020). An overview on coronaviruses family from past to COVID-19: introduce some inhibitors as antiviruses from Gillan\u2019s plants. Biointerface Res. Appl. Chem. 10 (3), 5575\u20135585. 10.33263/BRIAC103.575585", "ArticleIdList": ["10.33263/BRIAC103.575585"]}, {"Citation": "Mullen W., Boitier A., Stewart A. J., Crozier A. (2004). Flavonoid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. J. Chromatogr. A 1058 (1\u20132), 163\u2013168.", "ArticleIdList": ["15595664"]}, {"Citation": "Narkhede R. R., Pise A. V., Cheke R. S., Shinde S. D. (2020). Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): in-silico evidences. Nat. Prod. Bioprospect. 15, 1\u201310.", "ArticleIdList": ["PMC7299459", "32557405"]}, {"Citation": "Nguyen T. T., Woo H. J., Kang H. K., Nguyen V. D., Kim Y. M., Kim D. W., et al. (2012). Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 34 (5), 831\u2013838. 10.1007/s10529-011-0845-8", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Omar S., Bouziane I., Bouslama Z., Djemel A. (2020). In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2."}, {"Citation": "Pandit M., Latha N. (2020). In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection."}, {"Citation": "Park J. Y., Kim J. H., Kim Y. M., Jeong H. J., Kim D. W., Park K. H., et al. (2012). Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 20 (19), 5928\u20135935. 10.1016/j.bmc.2012.07.038", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park J. Y., Kim J. H., Kwon J. M., Kwon H. J., Jeong H. J., Kim Y. M., et al. (2013). Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg. Med. Chem. 21 (13), 3730. 10.1016/j.bmc.2013.04.026", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Park J. Y., Ko J. A., Kim D. W., Kim Y. M., Kwon H. J., Jeong H. J., et al. (2016). Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzym. Inhib. Med. Chem. 31 (1), 23\u201330. 10.3109/14756366.2014.1003215", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J. Y., Yuk H. J., Ryu H. W., Lim S. H., Kim K. S., Park K. H., et al. (2017). Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzym. Inhib. Med. Chem. 32 (1), 504\u2013515. 10.1080/14756366.2016.1265519", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Petersen E., Koopmans M., Go U., Hamer D. H., Petrosillo N., Castelli F., et al. (2020). Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis.", "ArticleIdList": ["PMC7333991", "32628905"]}, {"Citation": "Rahman N., Basharat Z., Yousuf M., Castaldo G., Rastrelli L., Khan H. (2020). Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2). Molecules 25 (10), 2271. 10.3390/molecules25102271", "ArticleIdList": ["10.3390/molecules25102271", "PMC7287752", "32408547"]}, {"Citation": "Rao S. V., Tulasi D., Pavithra K., Nisha R., Taj R. (2018). In silico studies on dengue and MERS coronavirus proteins with selected Coriandrum sativum l. herb constituents. World J. Pharm. Pharmaceut. Sci. 7 (12), 1\u201320. 10.1371/journal.pntd.0006618", "ArticleIdList": ["10.1371/journal.pntd.0006618"]}, {"Citation": "Ryu Y. B., Kim J. H., Park S. J., Chang J. S., Rho M. C., Bae K. H., et al. (2010). Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg. Med. Chem. Lett 20 (3), 971\u2013974. 10.1016/j.bmcl.2009.12.106", "ArticleIdList": ["10.1016/j.bmcl.2009.12.106", "20064716"]}, {"Citation": "Ryu Y. B., Park S. J., Kim Y. M., Lee J. Y., Seo W. D., Chang J. S., et al. (2010). SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii . Bioorg. Med. Chem. Lett 20 (6), 1873\u20131876. 10.1016/j.bmcl.2010.01.152", "ArticleIdList": ["10.1016/j.bmcl.2010.01.152", "PMC7127101", "20167482"]}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., et al. (2019). High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J. Virol. 93 (12), e00023\u201300019. 10.1128/JVI.00023-19", "ArticleIdList": ["10.1128/JVI.00023-19", "PMC6613765", "30918074"]}, {"Citation": "Smith M., Smith J. C. (2020). Repurposing therapeutics for COVID-19: supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface."}, {"Citation": "Song Y. H., Kim D. W., Curtis-Long M. J., Yuk H. J., Wang Y., Zhuang N., et al. (2014). Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. Biol. Pharm. Bull. 37 (6), 1021\u20131028. 10.1248/bpb.b14-00026", "ArticleIdList": ["10.1248/bpb.b14-00026", "24882413"]}, {"Citation": "Su W.-W., Wang Y.-G., Li P.-B., Wu H., Zeng X., Shi R., et al. (2020). The potential application of the traditional Chinese herb Exocarpium Citri grandis in the prevention and treatment of COVID-19. Traditional Medicine Research 5 (3), 160\u2013166."}, {"Citation": "Tahir ul Qamar M., Alqahtani S. M., Alamri M. A., Chen L. L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 10 (4), 313\u2013319 10.1016/j.jpha.2020.03.009", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "ter Ellen B., Kumar N. D., Bouma E., Troost B., van de Pol D., van der Ende-Metselaar H., Nawijn M. (2020). Resveratrol and pterostilbene potently inhibit SARS-CoV-2 infection in vitro. bioRxiv."}, {"Citation": "Thabti I., Albert Q., Philippot S., Dupire F., Westerhuis B., Fontanay S., et al. (2020). Advances on antiviral activity of Morus spp. plant extracts: human coronavirus and virus-related respiratory tract infections in the spotlight. Molecules 25 (8), 12. 10.3390/molecules25081876", "ArticleIdList": ["10.3390/molecules25081876", "PMC7221944", "32325742"]}, {"Citation": "Wahedi H. M., Ahmad S., Abbasi S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. J. Biomol. Struct. Dyn., 5, 1\u201310. 10.1080/07391102.2020.1762743", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Wan Y., Shang J., Graham R., Baric R. S., Li F. (2020). Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94 (7), 12. 10.1128/JVI.00127-20", "ArticleIdList": ["10.1128/JVI.00127-20", "PMC7081895", "31996437"]}, {"Citation": "Wei P., Zhang T., Dong H., Chen Q., Mu X., Hu G. (2017). Anti-inflammatory and antiviral activities of cynanversicoside A and cynanversicoside C isolated from Cynanchum paniculatum in influenza A virus-infected mice pulmonary microvascular endothelial cells. Phytomedicine 36, 18\u201325. 10.1016/j.phymed.2017.09.009", "ArticleIdList": ["10.1016/j.phymed.2017.09.009", "29157813"]}, {"Citation": "Wen C. C., Kuo Y. H., Jan J. T., Liang P. H., Wang S. Y., Liu H. G., Lee C. K., et al. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50 (17), 4087\u20134095. 10.1021/jm070295s", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "\nWHO, WHO Coronavirus Disease (2020). COVID-19) dashboard. Available at: https://covid19.who.int/table. Data accessed: 2020/11/2, 9:37am CET\n"}, {"Citation": "Williamson G., Kerimi A. (2020). Testing of natural products in clinical trials targeting the SARS-CoV-2 (Coved-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem. Pharmacol. 178, 114123. 10.1016/j.bcp.2020.114123", "ArticleIdList": ["10.1016/j.bcp.2020.114123", "PMC7316054", "32593613"]}, {"Citation": "Wu C. Y., Jan J. T., Ma S. H., Kuo C. J., Juan H. F., Cheng Y. S., Hsu H. H., et al. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. U.S.A. 101 (27), 10012\u201310017. 10.1073/pnas.0403596101", "ArticleIdList": ["10.1073/pnas.0403596101", "PMC454157", "15226499"]}, {"Citation": "Yang Q., Wu B., Shi Y., Du X., Fan M., Sun Z., et al. (2012). Bioactivity-guided fractionation and analysis of compounds with anti-influenza virus activity from Gardenia jasminoides Ellis. Arch Pharm. Res. (Seoul) 35 (1), 9\u201317. 10.1007/s12272-012-0101-3", "ArticleIdList": ["10.1007/s12272-012-0101-3", "22297738"]}, {"Citation": "Yang X. H., Deng W., Tong Z., Liu Y. X., Zhang L. F., Zhu H., et al. (2007). Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp. Med. 57 (5), 450\u2013459.", "ArticleIdList": ["17974127"]}, {"Citation": "Yao K.-t., Liu M., Li X., Huang J., Cai H. (2020). Retrospective clinical analysis on treatment of novel coronavirus-infected pneumonia with traditional Chinese medicine Lianhua Qingwen. Chin. J. Exp. Tradit. Med. Form. 2020, 1\u20137. 10.1016/j.biopha.2020.110641", "ArticleIdList": ["10.1016/j.biopha.2020.110641"]}, {"Citation": "Yu M. S., Lee J., Lee J. M., Kim Y., Chin Y. W., Jee J. G., et al. (2012). Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 22 (12), 4049\u20134054. 10.1016/j.bmcl.2012.04.081", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Zhao J., Yang J., Xie Y. (2019). Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. Int. J. Pharm. 570, 118642. 10.1016/j.ijpharm.2019.118642", "ArticleIdList": ["10.1016/j.ijpharm.2019.118642", "31446024"]}, {"Citation": "Zhuang M., Jiang H., Suzuki Y., Li X., Xiao P., Tanaka T., et al. (2009). Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antivir. Res. 82 (1), 73\u201381. 10.1016/j.antiviral.2009.02.001", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "PMC7114128", "19428598"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "24"}, {"Year": "2020", "Month": "11", "Day": "17"}, {"Year": "2021", "Month": "3", "Day": "8", "Hour": "5", "Minute": "49"}, {"Year": "2021", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "2", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["33679384", "PMC7926205", "10.3389/fphar.2020.586993", "586993"]}}], "PubmedBookArticle": []}